Incretin hormones and beta cell function in chronic pancreatitis.

作者: Filip Krag Knop

DOI:

关键词:

摘要: Type 2 diabetes mellitus (T2DM) has been shown to be characterised by an almost abolished incretin effect. The effect refers the phenomenon of oral glucose eliciting a higher insulin response than intravenous at identical plasma profiles. It is conveyed two insulinotropic hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent polypeptide (GIP). GLP-1 GIP are secreted from small intestines in ingestion nutrients. defect T2DM virtually lost GIP. unknown whether primary event leading or arises as consequence diabetic state. To investigate this we studied patients with chronic pancreatitis (CP). Over time, CP leads secondary (DM). If DM exhibit characteristic type deficiencies normal tolerance that regard, it more likely these consequences state rather events T2DM. On other hand, if physiology preserved independently endocrine status CP, could represent pathogenetic defect. Three protocols have employed this. In study investigating postprandial responses 8 exocrine pancreatic insufficiency, without enzyme supplementation (PES), observed compared matched healthy subjects; and, further, PES increased patients. This suggests not only secretion hormones regulated mere presence nutrients intestine, but also assimilation such involved, well. Furthermore, gauged DM. Eight subjects were for comparison. was tolerant whereas strongly reduced DM, suggesting Lastly, investigated impaired GIP, most occurs conclusion, suggest that: 1) among CP; 2) stimulates GLP-1; 3) deteriorating homeostasis,

参考文章(182)
L Pérusse, G Thériault, C Bouchard, A Tremblay, C Leblanc, Inheritance of the amount and distribution of human body fat. International Journal of Obesity. ,vol. 12, pp. 205- 215 ,(1988)
C Orskov, M Bersani, A H Johnsen, P Højrup, J J Holst, Complete sequences of glucagon-like peptide-1 from human and pig small intestine. Journal of Biological Chemistry. ,vol. 264, pp. 12826- 12829 ,(1989) , 10.1016/S0021-9258(18)51561-1
C. Ørskov, S. Seier Poulsen, P. Kirkegaard, J. J. Holst, Pancreatic and intestinal processing of proglucagon in man Diabetologia. ,vol. 30, pp. 874- 881 ,(1987) , 10.1007/BF00274797
C Orskov, J J Holst, B Hartmann, M Bersani, H Kofod, A H Johnsen, Proglucagon processing in porcine and human pancreas. Journal of Biological Chemistry. ,vol. 269, pp. 18827- 18833 ,(1994) , 10.1016/S0021-9258(17)32241-X
S Mojsov, G Heinrich, I B Wilson, M Ravazzola, L Orci, J F Habener, Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. Journal of Biological Chemistry. ,vol. 261, pp. 11880- 11889 ,(1986) , 10.1016/S0021-9258(18)67324-7
Paul Georg Lankisch, Jutta Otto, Ingrid Erkelenz, Bernhard Lembcke, Pancreatic Calcifications: No Indicator of Severe Exocrine Pancreatic Insufficiency Gastroenterology. ,vol. 90, pp. 617- 621 ,(1986) , 10.1016/0016-5085(86)91115-7
Jacqueline M. E. Knapper, Linda M. Morgan, John M. Fletcher, Sarah M. Puddicombe, Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue. Journal of Nutrition. ,vol. 125, pp. 183- 188 ,(1995) , 10.1093/JN/125.2.183
Daniel J. Drucker, Glucagon-like peptide 2. The Journal of Clinical Endocrinology and Metabolism. ,vol. 86, pp. 1759- 1764 ,(2001) , 10.1210/JCEM.86.4.7386
J.J. Holst, C. Ørskov, O. Vagn Nielsen, T.W. Schwartz, Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut FEBS Letters. ,vol. 211, pp. 169- 174 ,(1987) , 10.1016/0014-5793(87)81430-8
Ulrike NOVAK, Andrew WILKS, Gary BUELL, Stephen McEWEN, Identical mRNA for preproglucagon in pancreas and gut. FEBS Journal. ,vol. 164, pp. 553- 558 ,(1987) , 10.1111/J.1432-1033.1987.TB11162.X